Complications of multiple myeloma

被引：50

作者：

Blade, Joan ^{[1
]}

Rosinol, Laura ^{[1
]}

机构：

[1] Hosp Clin Barcelona, Inst Hematol & Oncol, Postgrad Sch Hematol Farreras Valenti, Inst Invest Biomed August Pi & Sunyer, Barcelona, Spain

来源：

HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA | 2007年 / 21卷 / 06期

关键词：

D O I：

10.1016/j.hoc.2007.08.006

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Multiple myeloma, also known as myeloma or plasma cell myeloma, is a progressive hematologic disease. Complications of multiple myeloma include renal insufficiency, hematologic complications (anemia, bone marrow failure, bleeding disorders), infections, bone complications (pathologic fractures, spinal cord compression, hyercalcemia), and neurologic complications (spinal cord and nerve root compression, intracranial plasmacytomas, leptomeningeal involvement, among others). This article reviews these various complications connected to multiple myeloma, examining their various causes and possible treatment.

引用

页码：1231 / +

页数：17

共 50 条

[41] Cardiac and Renal Complications of Carfilzomib Therapy in Patients with Multiple Myeloma
Dimopoulos, Meletios A.
Roussou, Maria
Gavriatopoulou, Maria
Psimenou, Erasmia
Ziogas, Dimitrios
Eleutherakis-Papaiakovou, Evangelos
Fotiou, Despina
Migkou, Magdalini
Kanellias, Nikolaos
Panagiotidis, Ioannis
Ntalianis, Argyrios
Repasos, Evangelos
Papadopoulou, Elektra
Stamatelopoulos, Kimon
Manios, Efstathios
Pamboukas, Constantinos
Kontogiannis, Sofoklis
Terpos, Evangelos
Kastritis, Efstathios
BLOOD, 2016, 128 (22)
[42] Infectious Complications of Daratumumab-Containing Therapy for Multiple Myeloma
Johnsrud, Andrew
Susanibar, Sandra
Kamimoto, Jorge Jo
Johnsrud, Joyce
Kothari, Atul
Burgess, Mary
Schinke, Carolina D.
Thanendrarajan, Sharmilan
Zangari, Maurizio
Davies, Faith E.
Morgan, Gareth J.
Van Rhee, Frits
Crescencio, Juan Carlos Rico
BLOOD, 2017, 130
[43] Severe pulmonary complications after bortezomib treatment in multiple myeloma
Dun, Xiaoyi
Yuan, Zhengang
Fu, Weijun
Zhang, Chunyang
Hou, Jian
HEMATOLOGICAL ONCOLOGY, 2010, 28 (01) : 49 - 52
[44] Comparison of infectious complications with BCMA-directed therapies in multiple myeloma
Nath, Karthik
Shekarkhand, Tala
Nemirovsky, David
Derkach, Andriy
Costa, Bruno Almeida
Nishimura, Noriko
Farzana, Tasmin
Rueda, Colin
Chung, David J.
Landau, Heather J.
Lahoud, Oscar B.
Scordo, Michael
Shah, Gunjan L.
Hassoun, Hani
Maclachlan, Kylee
Korde, Neha
Shah, Urvi A.
Tan, Carlyn Rose
Hultcrantz, Malin
Giralt, Sergio A.
Usmani, Saad Z.
Shahid, Zainab
Mailankody, Sham
Lesokhin, Alexander M.
BLOOD CANCER JOURNAL, 2024, 14 (01):
[45] Cardiovascular Complications Associated with Multiple Myeloma Therapies: Incidence, Pathophysiology, and Management
Patel, Vivek G.
Cornell, Robert F.
CURRENT ONCOLOGY REPORTS, 2019, 21 (04)
[46] Cardiac complications in relapsed and refractory multiple myeloma patients treated with carfilzomib
Atrash, S.
Tullos, A.
Panozzo, S.
Bhutani, M.
Van Rhee, F.
Barlogie, B.
Usmani, S. Z.
BLOOD CANCER JOURNAL, 2015, 5 : e272 - e272
[47] RELAPSED AND REFRACTORY MULTIPLE MYELOMA, EVOLUTION AND COMPLICATIONS SINGLE CENTER EXPERIENCE
Ionita, I.
Cheveresan, L.
Iordache, M.
Calamar, D.
Ionita, C.
Oros, D.
Ionita, M.
Ionita, H.
HAEMATOLOGICA, 2016, 101 : 796 - 796
[48] Cardiovascular Complications Associated with Multiple Myeloma Therapies: Incidence, Pathophysiology, and Management
Vivek G. Patel
Robert F. Cornell
Current Oncology Reports, 2019, 21
[49] The Role of Denosumab for Prevention of Skeletal-Related Complications in Multiple Myeloma
Hageman, Kelly
Patel, Kiki Chandni
Mace, Kimberly
Cooper, Maryann R.
ANNALS OF PHARMACOTHERAPY, 2013, 47 (7-8) : 1069 - 1074
[50] Thrombotic complications in multiple myeloma: a report of three cases and review of the literature
Yonal Ipek
Hindilerden Fehmi
Besisik-Kalayoglu Sevgi
Sargin Deniz
Journal of Thrombosis and Thrombolysis, 2012, 33 : 197 - 201

← 1 2 3 4 5 →